July, 2024
July 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
Karen Knudsen: It is a privilege to have her join the American Cancer Society Board of Directors!
Jan 14, 2024, 09:53

Karen Knudsen: It is a privilege to have her join the American Cancer Society Board of Directors!

Karen Knudsen, CEO of the American Cancer Society and American Cancer Society Cancer Action Network, shared American Cancer Society’s post on LinkedIn and added:

“A trailblazer in the publishing and beauty industries, Desirée boasts an impressive track record of inspiring change. She brings invaluable leadership experience, and it is a privilege to have her join the American Cancer Society Board of Directors! Welcome, Desiree Rogers!”

Quoting American Cancer Society’s post:

“We welcome Desirée Rogers, CEO of Black Opal Beauty, to the 2024 Board of Directors. With an extensive background in leadership across various industries, she also serves on several boards including Stagwell, Inspired Entertainment, World Business Chicago and Northwestern Hospital. Her wealth of knowledge and commitment make her an invaluable addition to the American Cancer Society. Welcome, Desiree Rogers!”

Source: Karen Knudsen/LinkedIn and American Cancer Society/LinkedIn

Karen E. Knudsen is the CEO of the American Cancer Society (ACS) and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN). Prior to joining ACS, Dr. Knudsen served as executive vice president of Oncology Services and enterprise director for Sidney Kimmel Cancer Center at Jefferson Health. She also served as president for the Association of American Cancer Institutes (AACI), representing the 102 leading cancer centers in North America, and on the board of directors of the American Association for Cancer Research (AACR).

Dr. Knudsen currently holds leadership roles with some of the most important cancer entities in the United States. She serves on the board of advisors for the National Cancer Institute and on 12 external advisory boards for NCI-designated cancer centers. She is an active member of several committees with the American Society for Clinical Oncology (ASCO), in addition to serving on other academic and for-profit advisory boards.